The fallout from the F.D.A.’s rejection of a new treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.
Related Posts
The D.E.I. Industry, Scorned by the White House, Turns to ‘Safer’ Topics
To avoid government scrutiny, companies are asking for fewer trainings focused on race and gender and more on neurodivergence and generational differences.
Why Eliminating Coal Could Take a Long Time
A mining and processing business in California is replacing one coal plant but says another could stay online for many years.
OpenAI’s GPT-5 Launch Causes Backlash Due to Colder Responses
When OpenAI released a new version of ChatGPT, people were quick to protest its colder responses. Acknowledging the emotional attachment with chatbots, the company quickly […]